Biological Therapeutics Product Development Subject Matter Expert Consultants to Support the Development of Therapeutic Biotechnology Products (Biologics)

Closed Pre-Solicitation Posted

Solicitation number
NIH-NINDS-SBSSN-25-000977
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
Not on record
PSC
Not on record
Place of performance
Bethesda, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics development subject matter expert (SME) consultants to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. The required support covers all aspects of drug discovery and development through Phase 1 clinical trials, including chemistry, manufacturing, and controls (CMC), pharmacokinetics and pharmacodynamics (PK/PD), absorption, distribution, metabolism, and excretion (ADME), toxicology, regulatory affairs, medical writing, and quality assurance. NINDS is seeking vendors who can supply a broad array of Biologics SMEs across all modalities and cell and gene therapies to support programs such as BPN-Biologics, URGenT, and HEAL-PTDP. Respondents must demonstrate at least 10 years of relevant experience in biologics product development, and responses are limited to 10 pages, due by December 6, 2024.

This is an unrestricted procurement, with no set-aside designation. The notice does not identify any potential incumbents or provide details on award values or budget ranges. The key numerical detail is the requirement for Biologics SMEs with at least 10 years of relevant experience.

Notice text

The NINDS has a need for biological therapeutics development subject matter expert (SME) consultants to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. The support included in this contract will cover all aspects of drug discovery and development through the Phase 1 clinical trial, including but not limited to chemistry, manufacturing, and controls (CMC), assay development, pharmacokinetics and pharmacodynamics (PK/PD), absorption, distribution, metabolism, and excretion (ADME), toxicology, regulatory affairs, regulatory operations, medical writing, biostatistics, and quality assurance/quality control (QA/QC), and first-in-human trial planning and design. The NINDS is seeking vendors who can supply a broad array of Biologics subject matter experts, including all modalities and cell and gene therapies.

This requirement supports the NIH Biologics development projects under the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP), and other extramural or intramural NIH drug discovery and development programs.

Files

File Type Posted
Sources Sought_Biologics.pdf PDF

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors